Eli Lilly inks radiopharma deal worth up to $1.1B with Aktis - MSN

Privately held biotech Aktis Oncology announced Tuesday a collaboration agreement with Eli Lilly (NYSE:LLY) to develop cancer-targeting radiopharmaceutical drugs in a deal worth up to …

CouponFollow Extension

$1
OFF

Eli Lilly Inks Radiopharma Deal Worth Up To $1.1B With Aktis - MSN

4 weeks from now

Privately held biotech Aktis Oncology announced Tuesday a collaboration agreement with Eli Lilly (NYSE:LLY) to develop cancer-targeting radiopharmaceutical drugs in a deal worth up to …

msn.com

$1
OFF

Lilly Inks Potential $1.1B Radiopharma Deal With Aktis Oncology

4 weeks from now

May 21, 2024 · Lilly is also making an undisclosed equity investment in Aktis. The deal builds on previous investments in radiopharma. Lilly dropped $1.4 billion to acquire Point Biopharma in …

biospace.com

$1
OFF

Eli Lilly Inks Radiopharma Deal Worth Up To $1.1B With Aktis

4 weeks from now

May 21, 2024 · Eli Lilly (LLY) partners with Aktis Oncology to develop radiopharmaceutical drugs for cancer, in a deal worth up to $1.1B. Read more here.

seekingalpha.com

$60
OFF

Lilly Partners With Aktis, Deepening Radiopharma Investment

4 weeks from now

May 21, 2024 · Eli Lilly is partnering with biotechnology company Aktis Oncology to develop radiopharmaceuticals for cancer, agreeing to a deal that will pay the startup $60 million …

biopharmadive.com

$1
OFF

Lilly Bolsters Radiopharmaceuticals Portfolio Through $1.1B ...

4 weeks from now

Indianapolis, IN, May 21, 2024 (msn.com) -- In a strategic move to bolster its presence in the radiopharmaceuticals domain, Eli Lilly has forged a multi-target discovery collaboration …

jacobsmgt.com

$1
OFF

Eli Lilly And Aktis Enter $1bn Partnership To Develop Anticancer ...

4 weeks from now

May 23, 2024 · Eli Lilly has entered into a strategic multi-target discovery collaboration agreement with Aktis Oncology in a deal worth more than $1bn to develop novel anticancer …

pmlive.com

$1
OFF

Eli Lilly Inks Deal Worth Over $1.1B To Develop New ...

4 weeks from now

May 24, 2024 · Eli Lilly has inked a deal worth over $1 billion to develop new radiopharmaceuticals in concert with Aktis Oncology. Lilly will pay $60 million in cash upfront …

purdue.edu

$1
OFF

Aktis, Lilly Ink $1.1B Cancer Radiopharmaceutical Deal

4 weeks from now

May 21, 2024 · The radiopharmaceutical revolution rolls on as Eli Lilly and Co. builds on its prowess in the space with a deal that could bring Aktis Oncology Inc. $1.1 billion. The two plan …

bioworld.com

$60
OFF

Lilly, Aktis Sign Radiopharmaceuticals Pact - Chemical

4 weeks from now

May 23, 2024 · Eli Lilly and Company has tapped Boston biotechnology firm Aktis Oncology to make new radiopharmaceuticals for solid tumors. Lilly will pay Aktis $60 million up front and up …

acs.org

$60
OFF

Lilly, Aktis Sign Radiopharma Pact | C&EN Global Enterprise

4 weeks from now

May 27, 2024 · Eli Lilly and Company has tapped Boston biotechnology firm Aktis Oncology to make new radiopharmaceuticals for solid tumors. Lilly will pay Aktis $60 million up front and up …

acs.org

$140
OFF

Lilly Signs $140M Radiopharma Partnership With Radionectics

4 weeks from now

Jul 1, 2024 · Eli Lilly pays Aktis $60M upfront to further dial into radiopharma signal The biotech hauled in a $52.5 million series A at the start of this year, bringing the total the company had …

fiercebiotech.com

$140
OFF

Lilly Builds In Radiopharma With $140m Radionetics Deal

4 weeks from now

4 days ago · Eli Lilly pays $140m for a stake in ... Lilly paid $60 million upfront to use Aktis Oncology's technology to generate radiopharma candidates for solid tumours in a deal that …

pharmaphorum.com

$175
OFF

Big Pharma Backers Return For Aktis' $175M Series B

4 weeks from now

Sep 30, 2024 · Having banked $60 million from Eli Lilly in the spring, Aktis Oncology has now closed an upsized $175 million series B that saw the U.S. Big Pharma rejoin a range of big …

fiercebiotech.com

FAQs about Eli Lilly inks radiopharma deal worth up to $1.1B with Aktis - MSN Coupon?

What is aktis oncology doing with Eli Lilly?

Privately held biotech Aktis Oncology announced Tuesday a collaboration agreement with Eli Lilly ( NYSE: LLY) to develop cancer-targeting radiopharmaceutical drugs in a deal worth up to $1.1B in terms of milestone payments alone. ...

How much money will aktis receive from Eli Lilly?

Per the terms, Boston, Massachusetts-based Aktis will receive a $60M upfront payment, an equity investment from Eli Lilly ( LLY ), in addition to potential milestone payments worth up to $1.1B. ...

How much will Lilly pay for aktis oncology?

Meanwhile, in May, Lilly paid $60 million upfront to use Aktis Oncology's technology to generate radiopharma candidates for solid tumours in a deal that could be worth up to $1.1 billion. ...

How much is aktis vs Lilly worth?

On Tuesday, Lilly added more elements to its burgeoning radiopharma portfolio. Aktis took the other side of the deal, agreeing to use its platform to generate anticancer candidates against targets chosen by Lilly. The agreement is worth $60 million upfront, plus up to $1.1 billion in milestones. ...

Has Aktis partnered with Lilly?

Aktis has partnered with Lilly to discover and develop novel anticancer radiopharmaceuticals. Under the terms of the agreement, Aktis will receive a $60 million upfront cash payment for the collaboration in addition to an equity investment in Aktis by Lilly. ...

Will Eli Lilly buy radionetics oncology for $140 million?

Eli Lilly is continuing to pursue its newfound passion for radiopharmaceuticals, this time handing Radionetics Oncology $140 million in upfront cash to partner on its pipeline of G protein coupled receptor (GPCR) targeted drugs. ...